Distinct Germline Mutation Landscape and Clinical Implications in Chinese Colorectal Cancer: A Large‐Scale Genomic Analysis of 1094 Patients
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.71848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 27.05.2026. Verfasst von Liting Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Medical Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Germ-Line Mutation. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Objective
To investigate the prevalence, characteristics, and clinical implications of germline mutations in a consecutive cohort of Chinese colorectal cancer (CRC) patients, providing insights that may inform population‐specific genetic testing strategies.
Methods
A total of 1094 CRC patients from two centers were retrospectively analyzed using a 53‐gene hereditary cancer panel. Germline variants were classified according to ACMG/AMP guidelines. Clinical characteristics, molecular features, and survival outcomes were examined, and mutation frequencies were compared with published data.
Results
Germline pathogenic/likely pathogenic (P/LP) mutations were identified in 9.3% of patients, with mismatch repair (MMR) genes most frequently affected (4.2%). Higher mutation rates were associated with early‐onset CRC, nonmetastatic disease, and a family history of cancer. Compared to Western populations, Chinese patients showed significantly lower frequencies of MUTYH and APC mutations (both 0.4% vs. 2.0%, p < 0.01) but higher rates of MMR mutations. Among the 106 germline variants detected, 63.2% were in NCCN‐recommended genes, while 36.8% were found in non‐NCCN genes, primarily within homologous recombination repair and Fanconi anemia pathways. Patients harboring germline P/LP mutations had significantly better progression‐free survival (HR = 0.52, p < 0.001). Notably, 50.0% of mutation carriers had no family history, and 29.4% were diagnosed after age 65, highlighting the limitations of current criteria‐based testing strategies.
Conclusions
This study reveals distinct germline mutation patterns and clinical features in Chinese CRC patients, underscoring the need for population‐specific genetic testing and tailored screening to improve prevention, early detection, and personalized treatment in Asian populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Medical Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
- Department of Gastrointestinal Surgery, Affiliated Hospital of Hebei University, Hebei, China.
- Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Lu, L., Peng, X., Zhang, J., Ding, Y., Lu, J., Lin, H., Wu, H., Wang, X., & Ba, Y. (2026). Distinct Germline Mutation Landscape and Clinical Implications in Chinese Colorectal Cancer: A Large‐Scale Genomic Analysis of 1094 Patients. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71848
Vancouver
Lu L, Peng X, Zhang J, Ding Y, Lu J, Lin H, et al. Distinct Germline Mutation Landscape and Clinical Implications in Chinese Colorectal Cancer: A Large‐Scale Genomic Analysis of 1094 Patients. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71848
BibTeX
@article{Lu2026,
author = {Lu, Liting and Peng, Xinyu and Zhang, Jiaxin and Ding, Yixin and Lu, Junliang and Lin, Hengxue and Wu, Huanwen and Wang, Xicheng and Ba, Yi},
title = {Distinct Germline Mutation Landscape and Clinical Implications in Chinese Colorectal Cancer: A Large‐Scale Genomic Analysis of 1094 Patients},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.71848}
}
EUVIMED